Lixadesiran (sodium)
Lixadesiran sodium is a siRNA in STP705. It targets to COX-2. STP705 is composed of 2 siRNA oligonucleotides (Pixofisiran and Lixadesiran) that individually target TGF-β1 and COX-2 mRNA.
Product Specifications
UNSPSC
12352208
Target
COX
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Lixadesiran(sodium)]
References & Citations
[1]Nestor MS, Hetzel J, Awad N, Bhupalam V, Lu P, Molyneaux M. A Novel Injectable Polypeptide Nanoparticle Encapsulated siRNA Targeting TGF-β1 and COX-2 for Localized Fat Reduction II: Phase I Clinical Trial. J Cosmet Dermatol. 2025;24 (2) :e16722.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
047082 50 µg
Carbonic Anhydrase 9/CA9, Recombinant, Human, Fc-Tag, Active discontinued
Ask
View Details GTR15167976 1 Vial
Lentiviral mouse Cdpf1 shRNA (UAS) - Lentiviral mouse Cdpf1 shRNA (UAS, RFP) (100)
Ask
View Details 